Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin prophylaxis in patients treated with azacitidine
2017-000445-51Phase 3Completed
- Sponsor
- Centre Henri Becquerel
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) (2 arms), sponsored by Centre Henri Becquerel. Started Apr 2018; status: completed.
02
Drugs
levofloxacin
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2017-000445-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000445-51.